Hosted on MSN6h
Valneva’s chikungunya vaccine wins UK approval
Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...
infectiousdiseaseadvisor.com16h
Infection Risk After Colonization High Overall for Multiple AMR Pathogens
Patients colonized with AMR pathogens showed high risk for infection with the same pathogen for up to 2 years, indicating a time window for decolonization interventions.
emjreviews.com17h
First and only chikungunya vaccine approved in UK
The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the ...
Valneva Receives Marketing Authorization in the UK for the World's First Chikungunya Vaccine, IXCHIQ
February 5, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) ...